E
Enric Carreras
Researcher at Radboud University Nijmegen
Publications - 28
Citations - 1806
Enric Carreras is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Hematopoietic stem cell transplantation & Transplantation. The author has an hindex of 12, co-authored 28 publications receiving 1761 citations.
Papers
More filters
Journal ArticleDOI
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
Alois Gratwohl,Jo Hermans,JohnM. Goldman,William Arcese,Enric Carreras,Agnès Devergie,Francesco Frassoni,G. Gahrton,Kolb Hj,Dietger Niederwieser,Tapani Ruutu,J P Vernant,T. de Witte,Jane F. Apperley +13 more
TL;DR: In this paper, a simple system based on five main factors gives adequate risk assessment for counselling of patients and taking decisions, which is highly predictive for leukaemia-free survival, survival and transplant-related mortality.
Journal ArticleDOI
Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Alois Gratwohl,Jakob Passweg,Chiara Bocelli-Tyndall,A Fassas,J.M. van Laar,Dominique Farge,M Andolina,Renate Arnold,Enric Carreras,Jürgen Finke,Ina Kötter,Tomas Kozak,I. Lisukov,Bob Löwenberg,Alberto M. Marmont,John Moore,Riccardo Saccardi,John A. Snowden,F.H.J. van den Hoogen,NM Wulffraat,X. Zhao,Alan Tyndall +21 more
TL;DR: Data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
Journal ArticleDOI
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome
Volker Runde,T. de Witte,Renate Arnold,A. Gratwohl,Jo Hermans,A. van Biezen,Dietger Niederwieser,M. Labopin,M.P. Walter-Noel,Almalina Bacigalupo,Niels Jacobsen,Per Ljungman,Enric Carreras,Kolb Hj,Carlo Aul,J. F. Apperley +15 more
TL;DR: It is concluded that patients with myelodysplasia who have appropriate marrow donors, especially those aged less than 40 years and those with low medullary blast cell count should be treated with BMT as the primary treatment early in the course of their disease.
Journal ArticleDOI
Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.
A. Gratwohl,Jo Hermans,J. F. Apperley,William Arcese,Almalina Bacigalupo,Giuseppe Bandini,P di Bartolomeo,Marc Boogaerts,Alberto Bosi,Enric Carreras +9 more
TL;DR: The Working Party Chronic Leukemia of the European Group for Bone Marrow Transplantation analyzed data of 1,294 patients transplanted from an allogeneic donor for chronic myelogenous leukemia (CML) in first chronic phase and tested the predictive value of aGVHD grading for the following end-points, documenting the value of the present 5-point grading.
Journal ArticleDOI
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
F van Rhee,Richard Szydlo,Jo Hermans,Agnès Devergie,Francesco Frassoni,William Arcese,T. de Witte,Kolb Hj,D Niederwiser,Niels Jacobsen,G. Gahrton,Giuseppe Bandini,Enric Carreras,Almalina Bacigalupo,Mauricette Michallet,Tapani Ruutu,Josy Reiffers,J. M. Goldman,J. F. Apperley,Alois Gratwohl +19 more
TL;DR: It is concluded that bone marrow transplantation can induce long-term survival in approximately one-half of CML patients; the majority of survivors have no evidence of residual leukemia cells when studied by molecular techniques.